Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01964638 · ClinicalTrials.gov registry record · NA
Use of Multi-Parametric MRI With Prostate Biopsy for Cancer Diagnosis.
A NA study of Prostate Cancer, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 126
- Enrollment target
- 1
- Study location
NCT01964638: Completed NA study of Prostate Cancer, sponsored by NYU Langone Health.
NCT01964638 is a NA study of Prostate Cancer that has completed, run by NYU Langone Health. The registered enrollment target is 126 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01964638, a NA study of Prostate Cancer, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective single center trial to examine the rates of cancer diagnosis when using computerized software to target suspicious lesions within the prostate identified on mpMRI. The primary evaluation involves comparing the rate of cancer diagnosis when using software-based MRI-Ultrasound image fusion guided biopsy to sample mpMRI findings to the use of visual guided biopsy (cognitive or mental targeting) of the same target. The hypothesis being tested is that fusion guided biopsy will increase detection prostate cancer within mpMRI findings as compared to visual guided biopsy of these areas
Primary Outcome
The primary endpoint of the study is the evaluation of the rates of prostate cancer diagnosis using software based MRI-TRUS imaging fusion targeting of mpMRI lesions as compared to cognitive co-registration and targeting of mpMRI lesions.
Conditions Studied
Interventions
- PROCEDURE Targeted Biopsy
Study Locations (1)
New York
- NYU Smilow Prostate Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-03 |
| Phase | NA |
What the finished NCT01964638 record still lists
NCT01964638 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Targeted Biopsy is the first listed.
NCT01964638 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01964638 about?
NCT01964638 is a clinical study titled "Use of Multi-Parametric MRI With Prostate Biopsy for Cancer Diagnosis.". This is a prospective single center trial to examine the rates of cancer diagnosis when using computerized software to target suspicious lesions within the prostate identified on mpMRI. The primary evaluation involves comparing the rate of cancer diagnosis when using software-based MRI-Ultrasound im...
What is the current status of trial NCT01964638?
This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2012-06. Estimated completion is 2013-03.
What conditions does trial NCT01964638 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT01964638?
The interventions under investigation include: Targeted Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01964638?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01964638 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01964638's enrollment target sits among peer trials
126 296th of 735 higher than 440 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia